Europa Biosite has announced the acquisition of Stratech Scientific through its UK subsidiary, Cambridge Bioscience. This strategic move further reinforces Europa Biosite’s position in the UK life science market and significantly broadens its research product portfolio.
Stratech Scientific is a well-established and highly respected UK distributor of life science reagents, known for its high-quality research products, long-standing supplier partnerships, and strong relationships within academic and industrial research communities.
By integrating Stratech Scientific into Cambridge Bioscience, Europa Biosite enhances its ability to serve universities, biotechnology companies, and pharmaceutical research organizations across the United Kingdom.
The combined organization will offer:
This complementary portfolio integration strengthens product availability, technical expertise, and customer support services throughout the UK market.
The acquisition aligns with Europa Biosite’s long-term strategy to build a high-performance, pan-European life science distribution network. Through targeted acquisitions and a strong focus on commercial excellence, the group continues to expand its footprint in key European markets.
Adding Stratech Scientific represents another meaningful milestone in Europa Biosite’s growth journey. It reinforces the company’s ambition to provide one of the most comprehensive life science reagent portfolios in Europe while remaining a preferred partner for both suppliers and researchers.
With an active M&A-driven expansion strategy, Europa Biosite continues to explore new acquisition opportunities to strengthen its presence across Europe.
For more information, visit:
https://www.europabiosite.com/europa-biosite-acquires-stratech-scientific